Duyuru • May 02
Core Laboratories Inc. Approves Cash Dividend, Payable on June 1, 2026 Core Laboratories Inc. announced on April 29, 2026, the Board approved a cash dividend of $0.01 per share of common stock, payable on June 1, 2026, to shareholders of record on May 11, 2026. Duyuru • Apr 01
Core Laboratories Inc., Annual General Meeting, May 12, 2026 Core Laboratories Inc., Annual General Meeting, May 12, 2026. Location: hotel zaza, memorial city, 9787 katy freeway, texas 77024, houston, United States Duyuru • Mar 04
Core Laboratories Inc. announced delayed annual 10-K filing On 03/03/2026, Core Laboratories Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Duyuru • Feb 05
Core Laboratories Inc. Approves a Cash Dividend, Payable on March 9, 2026 On February 4, 2026, the Board of Core Laboratories Inc. approved a cash dividend of $0.01 per share of common stock, payable on March 9, 2026, to shareholders of record on February 16, 2026. Duyuru • Jan 06
Core Laboratories Inc. to Report Q4, 2025 Results on Feb 04, 2026 Core Laboratories Inc. announced that they will report Q4, 2025 results After-Market on Feb 04, 2026 Duyuru • Oct 01
Core Laboratories Inc. (NYSE:CLB) acquired Solintec Consultoria E Servicos De Geologia Ltda. Core Laboratories Inc. (NYSE:CLB) acquired Solintec Consultoria E Servicos De Geologia Ltda on September 30, 2025. This acquisition will further enhance Core Lab’s presence to deliver the most comprehensive suite of reservoir laboratory services in the region and long-term, sustainable value for its clients and shareholders.
Core Laboratories Inc. (NYSE:CLB) completed the acquisition of Solintec Consultoria E Servicos De Geologia Ltda on September 30, 2025. Duyuru • Sep 25
Core Laboratories Inc. to Report Q3, 2025 Results on Oct 22, 2025 Core Laboratories Inc. announced that they will report Q3, 2025 results After-Market on Oct 22, 2025 Duyuru • Jun 25
Core Laboratories Inc. to Report Q2, 2025 Results on Jul 23, 2025 Core Laboratories Inc. announced that they will report Q2, 2025 results After-Market on Jul 23, 2025 Duyuru • Apr 24
Core Laboratories Inc. Approves Cash Dividend, Payable on May 27, 2025 On April 23, 2025, the Board of Core Laboratories Inc. approved a cash dividend of $0.01 per share of common stock payable on May 27, 2025, to shareholders of record on May 5, 2025. Duyuru • Apr 02
Core Laboratories Inc., Annual General Meeting, May 21, 2025 Core Laboratories Inc., Annual General Meeting, May 21, 2025. Location: at the hotel zaza, memorial city, 9787 katy freeway, texas 77024, houston, United States Duyuru • Mar 25
Core Laboratories Inc. to Report Q1, 2025 Results on Apr 23, 2025 Core Laboratories Inc. announced that they will report Q1, 2025 results at 4:00 PM, US Eastern Standard Time on Apr 23, 2025 Duyuru • Jan 04
Core Laboratories Inc. to Report Q4, 2024 Results on Jan 29, 2025 Core Laboratories Inc. announced that they will report Q4, 2024 results After-Market on Jan 29, 2025 Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €20.20, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 7x in the Energy Services industry in Europe. Total loss to shareholders of 14% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €25.65 per share. Declared Dividend • Oct 28
Third quarter dividend of US$0.01 announced Shareholders will receive a dividend of US$0.01. Ex-date: 4th November 2024 Payment date: 25th November 2024 Dividend yield will be 0.2%, which is lower than the industry average of 2.7%. Payout Ratios Payout ratio: 7%. Cash payout ratio: 4%. Reported Earnings • Oct 24
Third quarter 2024 earnings released: EPS: US$0.25 (vs US$0.20 in 3Q 2023) Third quarter 2024 results: EPS: US$0.25 (up from US$0.20 in 3Q 2023). Revenue: US$134.4m (up 7.2% from 3Q 2023). Net income: US$11.7m (up 27% from 3Q 2023). Profit margin: 8.7% (up from 7.4% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 2.9% growth forecast for the Energy Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Oct 23
Now 23% undervalued The stock has been flat over the last 90 days, currently trading at €15.90. The fair value is estimated to be €20.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.5% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 11% in 2 years. Earnings are forecast to grow by 123% in the next 2 years. Duyuru • Sep 25
Core Laboratories Inc. to Report Q3, 2024 Results on Oct 23, 2024 Core Laboratories Inc. announced that they will report Q3, 2024 results After-Market on Oct 23, 2024 Buy Or Sell Opportunity • Aug 06
Now 43% undervalued The stock has been flat over the last 90 days, currently trading at €12.30. The fair value is estimated to be €21.72, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.5% over the last 3 years. Earnings per share has grown by 16%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 20% per annum over the same time period. Upcoming Dividend • Jul 31
Upcoming dividend of US$0.01 per share Eligible shareholders must have bought the stock before 05 August 2024. Payment date: 26 August 2024. Payout ratio is a comfortable 7.9% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (3.8%). Declared Dividend • Jul 31
Second quarter dividend of US$0.01 announced Shareholders will receive a dividend of US$0.01. Ex-date: 5th August 2024 Payment date: 26th August 2024 Dividend yield will be 0.2%, which is lower than the industry average of 2.7%. Payout Ratios Payout ratio: 8%. Cash payout ratio: 6%. Duyuru • Jun 26
Core Laboratories Inc. to Report Q2, 2024 Results on Jul 24, 2024 Core Laboratories Inc. announced that they will report Q2, 2024 results After-Market on Jul 24, 2024 Declared Dividend • Apr 29
First quarter dividend of US$0.01 announced Shareholders will receive a dividend of US$0.01. Ex-date: 3rd May 2024 Payment date: 28th May 2024 Dividend yield will be 0.2%, which is lower than the industry average of 2.7%. Payout Ratios Payout ratio: 5%. Cash payout ratio: 9%. Duyuru • Apr 26
Core Laboratories Inc. Approves Cash Dividend, Payable on May 28, 2024 On April 24, 2024, the Board of Core Laboratories Inc. approved a cash dividend of $0.01 per share of common stock payable on May 28, 2024 to shareholders of record on May 6, 2024. Reported Earnings • Apr 25
First quarter 2024 earnings released: EPS: US$0.068 (vs US$0.051 in 1Q 2023) First quarter 2024 results: EPS: US$0.068 (up from US$0.051 in 1Q 2023). Revenue: US$129.6m (up 1.0% from 1Q 2023). Net income: US$3.22m (up 36% from 1Q 2023). Profit margin: 2.5% (up from 1.8% in 1Q 2023). Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 1.3% growth forecast for the Energy Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Duyuru • Mar 26
Core Laboratories Inc. to Report Q1, 2024 Results on Apr 24, 2024 Core Laboratories Inc. announced that they will report Q1, 2024 results After-Market on Apr 24, 2024 Duyuru • Mar 20
Core Laboratories Inc., Annual General Meeting, May 08, 2024 Core Laboratories Inc., Annual General Meeting, May 08, 2024, at 09:00 Central Daylight. Location: Hotel Zaza, Memorial City, 9787 Katy Freeway Houston Texas United States Agenda: To re-elect two current Class III Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2027 and until their successors shall have been duly elected and qualified; to ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the year ending December 31, 2024; to approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis, and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables; and to discuss other matters. Duyuru • Oct 05
Core Laboratories Inc. to Report Q3, 2023 Results on Nov 01, 2023 Core Laboratories Inc. announced that they will report Q3, 2023 results After-Market on Nov 01, 2023 Reported Earnings • Jul 27
Second quarter 2023 earnings released: EPS: US$0.49 (vs US$0.15 in 2Q 2022) Second quarter 2023 results: EPS: US$0.49 (up from US$0.15 in 2Q 2022). Revenue: US$127.9m (up 5.8% from 2Q 2022). Net income: US$22.8m (up 223% from 2Q 2022). Profit margin: 18% (up from 5.8% in 2Q 2022). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Energy Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Duyuru • Jul 04
Core Laboratories Inc. Approves to Elect Curtis Anastasio as Class I Director Core Laboratories Inc. announced at the AGM held on June 28, 2023 that the company approved to elect Curtis Anastasio as Class I Director. Duyuru • Jun 28
Core Laboratories Inc. to Report Q2, 2023 Results on Jul 26, 2023 Core Laboratories Inc. announced that they will report Q2, 2023 results After-Market on Jul 26, 2023 
